PAPILLARY THYROID CARCINOMA CONCOMITANT WITH THYROTOXICOSIS
Contrary to the preconceived belief, the occurrence of hyperthyroidism in patients with thyroid cancer is gaining in incidence. The research team retrospectively analysed studies such as serum TSH and T4 levels, thyroid ultrasound results, and the histopathology reports of 9 patients (age range 20-67) from Mardaleishvili Medical Center. All patients were diagnosed with PTC. 7 patients had microcarcinoma (mean 6.1mm) and 2 – large tumors (mean 14mm). Graves’ disease was found in 5 patients, toxic nodular goiter in 3 and one patient’s record was lacking comorbid disease information. One patient had confirmed lymph node involvement. All patients underwent total thyroidectomy. Overall, all 9 patients with hyperthyroidism were subsequently diagnosed with thyroid cancer. Management of such patients has questioned the validity of the guidelines published by the ATA and emphasizes the fact that malignancy should not be excluded in patients with thyrotoxicosis.
Du L, Wang Y, Sun X et al. Thyroid cancer: Trends in incidence, mortality and clinical-pathological patterns in Zhejiang Province, Southeast China. BMC Cancer 2018;18;291.
Greene R, Piercy JE, Singer W. Thyroid nodules and cancer. BMJ 1964;2(5424):1595.
Haugen BR, Alexander EK, Bible KC, et al. American thyroid association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American thyroid association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26(1):1–133.
Lee K, Anastasopoulou C, Chandran C, Cassaro S. (2021). Thyroid cancer. In StatPearls. StatPearls Publishing. (https://www.ncbi.nlm.nih.gov/books/NBK459299/)
Olson E, Wintheiser G, Wolfe KM, Droessler J, Silberstein PT. (n.d.). Epidemiology of thyroid cancer: A review of the national cancer database, 2000- 2013. Cureus 2019 Feb 24;11(2): e4127
Pazaitou-Panayiotou K, Michalakis K, Paschke R. Thyroid cancer in patients with hyperthyroidism. HormMetab Res2012;44(4):255–62.
Rahib L, Smith BD, Aizenberg R, Rosenzweig AB., Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Research 2014;74(11):2913–21.
Ren M, Wu MC, Shang CZ, et al. Predictive factors of thyroid cancer in patients with Graves’ disease. World JSurg2014;38(1):80–87.
Sharma, S. D., Kumar, G., Guner, K., &Kaddour, H. (2016). Hyperthyroidism inpatients with thyroid cancer. ENT J 95(6):236–39.
Staniforth JUL, Erdirimanne S, Eslick GD. Thyroid carcinoma in Graves’ disease: A meta-analysis. Int JSurg (London, England), 2016;27:118–25.